HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wella Yardley North America Acquisition To Globalize Brand

This article was originally published in The Rose Sheet

Executive Summary

Wella's acquisition of Yardley of London's North American business from New York City-based Wasserstein & Co. may give the company an opportunity to introduce its European stable of upscale Yardley offerings to the U.S. market, Yardley said

You may also be interested in...



Yardley Steps Into Children’s Ring With Piccadilly Circus Bath Line

Building on its British heritage, Yardley of London is introducing a Piccadilly Circus children's bath line targeting children ages three and older. Shipping to mass market stores now, the line is designed to make bath time fun with a slew of innovative products, the company said

Yardley Steps Into Children’s Ring With Piccadilly Circus Bath Line

Building on its British heritage, Yardley of London is introducing a Piccadilly Circus children's bath line targeting children ages three and older. Shipping to mass market stores now, the line is designed to make bath time fun with a slew of innovative products, the company said

Wella Cosmetics & Fragrances Sales Up Nearly 12% On Acquired Brands

Sales of Wella's Cosmetics & Fragrances division advanced 11.8% to $295 mil. (€1=$.98) for the first six months of 2002, fueled by the addition of several recently-purchased brands, the Darmstadt, Germany firm said during 1its mid-year sales and earnings presentation Aug. 14

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009896

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel